---
$id: https://graph.org.ai/products/commodity/51172481
$type: Product
source: UNSPSC
code: "51172481"
title: "Laronidase"
class: "51172400"
classTitle: "Combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations"
family: "51170000"
familyTitle: "Drugs affecting the gastrointestinal system"
segment: "51000000"
segmentTitle: "Pharmaceutical Products incl. Contraceptives and Vaccines"


---

# Laronidase

**UNSPSC Code**: 51172481
**Class**: [Combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations](Combination antacid, antidiarrheal, anti-flatulence, digestive, and gastric preparations.mdx)
**Family**: [Drugs affecting the gastrointestinal system](../Drugs affecting the gastrointestinal system.mdx)
**Segment**: [Pharmaceutical Products incl. Contraceptives and Vaccines](../../Pharmaceutical Products incl. Contraceptives and Vaccines.mdx)

Laronidase is a form of recombinant human alpha-L-iduronidase used to treat Hurler and Hurler-Scheie forms of mucopolysaccharidosis, a genetic deficiency of alpha-L-iduronidase

